Showing results (91-100 of 108) with videos related to
Sort By:
Pageof 11
Cerebral Cortex (New York, N.Y. : 1991)|February 17, 2006
Cognitive inflexibility after prefrontal serotonin depletion is behaviorally and neurochemically specificH F Clarke, S C Walker, J W Dalley, et al.Journal of Clinical Anesthesia|September 1, 1996
A mixture of mivacurium and rocuronium is comparable in clinical onset to succinylcholineJ B Stevens, J M Shephered, P A Vories, et al.The European Journal of Neuroscience|July 6, 2006
Selective prefrontal serotonin depletion impairs acquisition of a detour-reaching taskS C Walker, Y P Mikheenko, L D Argyle, et al.Radiology|December 1, 1989
Modulation of liver tumor blood flow with hepatic arterial epinephrine: a SPECT studyJ C Andrews, S C Walker-Andrews, J E Juni, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 1, 1994
Hepatic radioembolization with yttrium-90 containing glass microspheres: preliminary results and clinical follow-upJ C Andrews, S C Walker, R J Ackermann, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 14, 2005
Prefrontal serotonin depletion affects reversal learning but not attentional set shiftingH F Clarke, S C Walker, H S Crofts, et al.Veterinary Research|January 1, 1995
Characterization of IHNV isolates associated with neurotropismS E LaPatra, K A Lauda, G R Jones, et al.Radiology|April 1, 1993
Hepatic parenchymal changes after intraarterial Y-90 therapy: CT findingsC S Marn, J C Andrews, I R Francis, et al.Diabetes Research and Clinical Practice|July 1, 1997
Mortality following lower extremity amputation in minorities with diabetes mellitusL A Lavery, W H van Houtum, D G Armstrong, et al.Cancer Research|April 15, 1994
Clinical pharmacology of hepatic arterial infusions of 5-bromo-2'-deoxyuridineW D Ensminger, S C Walker, P L Stetson, et al.Pageof 11